Maximizing the natriuretic peptide system in experimental heart failure: Subcutaneous brain natriuretic peptide and acute vasopeptidase inhibition

Circulation

Volumn 105, Issue 8, 2002, Pages 999-1003

  Chen, Horng H ^a   Lainchbury, John G ^a   Harty, Gail J ^a   Burnett Jr , John C ^a  

^a MAYO CLINIC   (United States)

Author keywords

Heart failure; Natriuretic peptides; Pacing

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE; MEMBRANE METALLOENDOPEPTIDASE; NATRIURETIC FACTOR; OMAPATRILAT; SODIUM; VASOPEPTIDASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; CONGESTIVE HEART FAILURE; DOG; DRUG MECHANISM; DRUG POTENTIATION; ENZYME INHIBITION; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART FUNCTION; HEART OUTPUT; HEART VENTRICLE PACING; KIDNEY FUNCTION; MALE; NONHUMAN; PRIORITY JOURNAL; SODIUM URINE LEVEL; URINARY EXCRETION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ATRIAL NATRIURETIC FACTOR; CARDIAC PACING, ARTIFICIAL; CYCLIC GMP; DISEASE MODELS, ANIMAL; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; GLOMERULAR FILTRATION RATE; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; INJECTIONS, SUBCUTANEOUS; KIDNEY; MALE; NATRIURETIC PEPTIDE, BRAIN; NEPRILYSIN; PEPTIDYL-DIPEPTIDASE A; PYRIDINES; SODIUM; THIAZEPINES;

EID: 0037176972     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc0802.104282     Document Type: Article

References (22)

1. Atrial natriuretic peptide elevation in congestive heart failure in the human
2. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure
3. Effects of synthetic atrial natriuretic factor on renal function and renin release
4. Effects of the endogenous natriuretic peptide system on ventricular and coronary function in the failing heart
5. The effects of pathophysiological increments in brain natriuretic peptide in left ventricular systolic dysfunction
6. A function role for endogenous atrial natriuretic peptide in a canine model of early left ventricular dysfunction
7. Salt-resistant hypertension in mice lacking guanylyl cyclase-A receptor for atrial natriuretic peptide
8. Intravenous Nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure: Nesiritide study group
9. Subcutaneous administration of brain natriuretic peptide in experimental heart failure
10. Dual metalloprotease inhibitors: Mercaptoacetyl-based fused heterocyclic dipeptide mimetics as inhibitors of angiotensin-converting enzyme and neutral endopeptidase
11. Combined inhibition of neutral endopeptidase and angiotensin converting enzyme in cardiomyopathic hamsters with compensated heart failure
12. Endogenous natriuretic peptides participate in renal and humoral actions of acute vasopeptidase inhibition in experimental mild heart failure
13. Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial
14. Clinical, cardiac, renal, arterial and neurohormonal effects of omapatrilat, a vasopeptidase inhibitor in patients with chronic heart failure
15. Cardiorenal and neurohumoral function in a canine model of early left ventricular dysfunction
16. Atrial natriuretic peptide elevation in congestive heart failure in man
17. BNP: Pathophysiological and potential therapeutic roles in acute congestive heart failure
18. Radioimmunoassay for cyclic nucleotidase
19. Application of a radioimmunoassay for angiotensin I to the physiological measurements of plasma renin activity in normal human subjects
20. A direct microassay for aldosterone in plasma extracts
21. Effects of natriuretic peptides on load and myocardial function in normal and heart failure dogs
22. Vasopeptidase inhibition: A new concept in blood pressure management